Value change is a phenomenon that is gaining increasing attention in ethical analyses of technologies. However, a comprehensive study of how reprogenetic technologies and values coevolve is lacking. To remedy this gap, in this overview article, I address the relationship between reprogenetics and value change. This contribution thus argues for the importance of investigating the phenomenon of value change in relation to the technological controversies discussed in bioethics. To meet this goal, I begin by clarifying, first, how technologies shape reproductive choice. I then clarify what "values" and "moral values" are, how reprogenetic technologies are value laden, and what values are often discussed in reprogenetics debates. Next, I show five types of value changes that have occurred in advance in reproductive and genetic technologies. Finally, I argue for the bioethical relevance of discussing future techno-value change, pointing out the descriptive and normative challenges of this philosophical endeavor.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/bioe.13287 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Moral equality and reprogenetic autonomy in the genomic era.
Politics Life Sci
October 2024
California Institute of Technology, Pasadena, CA, USA.
In this paper, I question the argument from human dignity found in the Universal Declaration on the Human Genome and Human Rights (UDHGHR) and in the recent views of the International Bioethics Committee (IBC). I focus on what this argument says about the permissibility of two broad categories of reprogenetic choices that may be available to prospective parents in the genomic era. The argument from human dignity holds that non-medical genetic selection and somatic enhancements ought to be prohibited because they violate the principle of human dignity.
View Article and Find Full Text PDFThe emergence and use of expanded carrier screening in gamete donation: A new form of repro-genetic selection.
Bioethics
January 2025
Centre for Reproduction Research, De Montfort University, Leicester, UK.
With the continued expansion and commercialisation of fertility treatments, the selection and matching of donors have become more sophisticated and technologised. As part of this landscape, new form of genetic screening: 'expanded carrier screening' (ECS) is being offered as a technique to avoid the risk of donors passing on genetic conditions to future offspring. Allowing donors to be tested for hundreds of genetic conditions simultaneously, ECS marks a considerable departure from traditional 'family history' models of screening, which rely on an individual's knowledge of family health.
View Article and Find Full Text PDFValue change, reprogenetic technologies, and the axiological underpinnings of reproductive choice.
Bioethics
May 2024
Department of Philosophy 1, University of Granada, Granada, Spain.
Value change is a phenomenon that is gaining increasing attention in ethical analyses of technologies. However, a comprehensive study of how reprogenetic technologies and values coevolve is lacking. To remedy this gap, in this overview article, I address the relationship between reprogenetics and value change.
View Article and Find Full Text PDFPolitics of reproduction: a view from Israel on the Dobbs decision.
Isr J Health Policy Res
January 2023
University of Haifa (Adjunct, Emeritus), Haifa, Israel.
Background: This opinion piece looks at the recent decision of the United States Supreme Court in Dobbs v. Jackson Women's Health Organization and then compares the law on abortion in the USA to the law in Israel on reproductive medicine in general. The Dobbs decision validated a Mississippi state law that restricted access to abortion, while overruling the landmark precedent of Roe v.
View Article and Find Full Text PDFWe need to talk about disruption in bioethics: a commentary on Rueda, Pugh and Savulescu.
Trends Biotechnol
June 2023
Bioethics Institute Ghent, Department of Philosophy and Moral Sciences, Ghent University, Ghent, Belgium; Research institutes GROW and CAPHRI, Department of Health, Ethics, and Society, Maastricht University, Maastricht, The Netherlands.
Rueda, Pugh, and Savulescu intervene in the debate of reprogenetic enhancement technologies that can lead to ethical disruption. In response, we think such innovations may not so much disrupt biomedical ethics but instead may reanimate older debates in this field.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!